Create Alert
Watchlist

Brooks Laboratories

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹447Cr
ROE-10.16%
P/E Ratio(TTM)220.07
EPS(TTM)0.69
P/B Ratio4.56
Dividend Yield0.00%
Industry P/E34.72
Book Value33.30
Debt to Equity0.08
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Brooks Laboratories

Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company working on a contract basis. The Company operates through the Pharmaceuticals segment. It manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup and eye/ear drops. Its products under Carbapenem category includes Imipenem 250mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 125mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, Doripenem 500mg and Doripenem 1000mg. It offers Penicillins in the form of injections, tablets and dry syrup. Its General category of products include liquid injections, dry powder injections and eye/ear drops. Its liquid injections include Iron sucrose 100mg/5ml, among others. The Company has manufacturing plants at Baddi, Himachal Pradesh. The Company manufactures and markets the pharmaceuticals nationally and internationally to various regulated markets.;
Parent OrganisationBrooks Laboratories
Managing DirectorMr. Rajesh Mahajan
NSE SymbolBROOKS

Shareholding Pattern

Sep '24
Dec '24
Jan '25
Mar '25
Jun '25
Promoters
52.62%
Retail And Others
37.00%
Mutual Funds
9.90%
Other Domestic Institutions
0.48%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
105.62
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.25
Emcure Pharmaceuticals
NA
(0.00%)
34.95
Wockhardt
NA
(0.00%)
-195.26